2018
DOI: 10.1213/ane.0000000000002903
|View full text |Cite
|
Sign up to set email alerts
|

Intrathecal Drug Delivery Systems for Refractory Pancreatic Cancer Pain: Observational Follow-up Study Over an 11-Year Period in a Comprehensive Cancer Center

Abstract: Despite our study's limitations, results suggest that long-term IDDS for refractory malignant pain due to pancreatic cancer was both efficacious and safe in pancreatic cancer pain. We have demonstrated, in the largest series of IDDS for pancreatic cancer pain reported yet, a clinically and statistically significant pain reduction in patients receiving IDDS.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

0
15
0
1

Year Published

2019
2019
2021
2021

Publication Types

Select...
7
2

Relationship

1
8

Authors

Journals

citations
Cited by 44 publications
(16 citation statements)
references
References 36 publications
0
15
0
1
Order By: Relevance
“…More recently, neuromodulation has been developed as a less invasive treatment option, including spinal cord stimulation and targeted intrathecal pharmacotherapy (eg, morphine pump) 32. While these are considered relatively safe and produce significant pain reduction, there is a lack of randomised placebo-controlled trials to support it 33 34…”
Section: The Cons Of Interventional Treatment Of Pain In Chronic Pancmentioning
confidence: 99%
“…More recently, neuromodulation has been developed as a less invasive treatment option, including spinal cord stimulation and targeted intrathecal pharmacotherapy (eg, morphine pump) 32. While these are considered relatively safe and produce significant pain reduction, there is a lack of randomised placebo-controlled trials to support it 33 34…”
Section: The Cons Of Interventional Treatment Of Pain In Chronic Pancmentioning
confidence: 99%
“…The primary outcome measure was a change in numerical rating scale (NRS) from pre‐implantation to post‐implantation. As part of IT dosing strategies, the authors do report a transition off of systemic opioid therapy but no specific measures are reported detailing the rate or degree of success (9).…”
Section: Discussionmentioning
confidence: 99%
“…Intrathecal drug delivery (IDD), also referred to as targeted drug delivery (TDD) or intrathecal therapy (ITT), has long been used for patients with inadequate pain control despite systemic opioid escalation or dose-limiting opioid-related side effects. IDD has been shown to improve analgesia, reduce medical costs, decrease hospital visits, reduce opioid-related side effects, decrease opioid consumption, effectively manage breakthrough pain, reduce serum opioid levels, and preserve quality of life in patients with severe cancer-related pain (6)(7)(8)(9)(10)(11)(12)(13). IDDS implantation carries risks, including infection, bleeding, neurologic injury, cerebrospinal fluid leak, and postdural puncture headache.…”
Section: Introductionmentioning
confidence: 99%
“…For these reasons, safe and effective alternative therapies are in high demand. These alternative therapies include CPN, celiac plexus block (CPB), splanchnicectomy, and intrathecal therapy [8][9][10].…”
Section: Discussionmentioning
confidence: 99%